Dev Prasad

Stock Analyst at LUCID CAPITAL MARKETS

(1.97)

# 2,906

Out of 4,786 analysts

3

Total ratings

33.33%

Success rate

11.53%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Dev Prasad

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	AVTX Avalo Therapeutics	Initiates: Buy	$24	$8.01	+199.63%	1	Dec 17, 2024
	IBIO iBio, Inc.	Initiates: Buy	$6	$4.02	+49.25%	1	Dec 17, 2024
	CALC CalciMedica	Initiates: Buy	$13	$1.91	+580.63%	1	Dec 17, 2024

Avalo Therapeutics

Dec 17, 2024

Initiates: Buy

Price Target: $24

Current: $8.01

Upside: +199.63%

iBio, Inc.

Dec 17, 2024

Initiates: Buy

Price Target: $6

Current: $4.02

Upside: +49.25%

CalciMedica

Dec 17, 2024

Initiates: Buy

Price Target: $13

Current: $1.91

Upside: +580.63%